SEC 13F Intelligence

Dekabank Deutsche Girozentrale / ABBV

Dekabank Deutsche Girozentrale’s Abbvie Inc Position

Does Dekabank Deutsche Girozentrale own Abbvie Inc (ABBV)? Yes3.05M shares worth $662M (+1.09% of its 13F portfolio) as of Q1 2026.

Position Value
$662M
Q1 2026
Shares
3.05M
% of Portfolio
+1.09%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $74MQ4 ’18Q1 ’19: $38MQ2 ’19: $64MQ3 ’19: $70MQ4 ’19: $82MQ4 ’19Q1 ’20: $70MQ2 ’20: $101MQ3 ’20: $159MQ1 ’21: $271MQ1 ’21Q2 ’21: $310MQ3 ’21: $314MQ4 ’21: $407MQ1 ’22: $429MQ1 ’22Q2 ’22: $418MQ3 ’22: $407MQ4 ’22: $522MQ1 ’23: $463MQ1 ’23Q2 ’23: $419MQ3 ’23: $472MQ4 ’23: $489MQ1 ’24: $554MQ1 ’24Q2 ’24: $547MQ3 ’24: $597MQ4 ’24: $542MQ1 ’25: $625MQ1 ’25Q2 ’25: $561MQ3 ’25: $681MQ4 ’25: $541MQ1 ’26: $662MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.05M$662M+1.09%
Q4 20253.05M$541M+0.94%
Q3 20253.05M$681M+1.15%
Q2 20253.05M$561M+1.00%
Q1 20253.08M$625M+1.23%
Q4 20243.05M$542M+1.00%
Q3 20243.05M$597M+1.11%
Q2 20243.21M$547M+0.98%
Q1 20243.08M$554M+1.03%
Q4 20233.18M$489M+1.00%
Q3 20233.09M$472M+1.09%
Q2 20233.12M$419M+0.94%
Q1 20232.95M$463M+1.17%
Q4 20223.22M$522M+1.38%
Q3 20222.88M$407M+1.20%
Q2 20222.74M$418M+1.22%
Q1 20222.61M$429M+1.05%
Q4 20212.99M$407M+0.99%
Q3 20212.87M$314M+0.88%
Q2 20212.76M$310M+0.90%
Q1 20212.53M$271M+0.90%
Q3 20201.82M$159M+0.70%
Q2 20201.04M$101M+0.64%
Q1 2020933.9K$70M+0.54%
Q4 2019915.0K$82M+0.50%
Q3 2019934.0K$70M+0.44%
Q2 2019904.0K$64M+0.32%
Q1 2019390.6K$38M+0.23%
Q4 2018818.6K$74M+0.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of ABBV.